It is an exciting time for cardiovascular science and medicine. Many of the most impressive strides in basic and translational cardiovascular research are happening right here at the Cardiovascular Research Center (CVRC) in the Icahn School of Medicine at Mount Sinai.
At the CVRC, our multi-disciplinary team of investigators is expanding our studies of the basic mechanisms of cardiovascular disease. We are exploring personalized medicine based on identifying genomic and epigenetic predictors. The highly collaborative environment uses resources within the Center and across the entire Mount Sinai Health System to create an environment for translational research that is patient driven, responsive, and cleverly targeted.
The Center has a diverse team of principal investigators, researchers, and trainees working across platforms and using modern technologies. We are investigating a variety of areas including stem cell biology, induced pluripotent stem cells, tissue engineering, gene therapy, vascular diseases, cardiovascular immunology, diabetic cardiomyopathy, preclinical translational models of cardiovascular diseases, state-of-the-art cardiovascular imaging, cardiovascular space radiobiology, and clinical trials. Our researchers are also exploring signaling pathways that lead to cardiopulmonary pathologies, cardiac hypertrophy, pulmonary fibrosis, and pulmonary arterial hypertension. We are testing novel therapeutic approaches for heart, vascular, and lung diseases. We aim to discover and develop innovative new ways to halt or reverse these devastating pathologies.
I invite you to explore our website, learn more about our current projects and investigators, and consider how you can contribute to the groundbreaking discoveries happening at Mount Sinai’s Cardiovascular Research Center to help prevent and reverse cardiovascular diseases.
Kevin D. Costa, PhD
Interim Director, Cardiovascular Research Center
Valentin Fuster, MD, PhD
Physician-in-Chief of The Mount Sinai Hospital
Director of Mount Sinai Heart